ACTIVATION OF THE SERINE PROTEINASE SYSTEM IN CHRONIC KIDNEY REJECTION1
- 1 June 1998
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Transplantation
- Vol. 65 (12), 1628-1634
- https://doi.org/10.1097/00007890-199806270-00015
Abstract
Activation of the serine proteinase system is an important mechanism that contributes to tissue remodeling. In the present study, we analyzed the expression of urokinase plasminogen activator (uPA), urokinase plasminogen activator receptor (uPAR), and plasminogen activator inhibitor type 1 (PAI-1) in samples of chronically rejected human kidneys. Using Northern blot analysis, immunohistochemistry, and a uPA activity assay, specimens from 10 chronically rejected kidneys and 10 normal kidney samples were analyzed. By Northern blot analysis, the expression of uPAR and PAI-1 mRNA was 2.9-fold (P<0.05) and 2.3-fold (P<0.05) increased in chronically rejected kidney samples, respectively, compared with normal controls. In contrast, uPA mRNA levels in chronically rejected kidneys were comparable to those in the normal controls. Immunohistochemical analysis in normal kidneys showed weak immunostaining of uPA, moderate to intense uPAR and PAI-1 immunostaining in proximal tubules, and moderate immunostaining in distal tubules, but no signal in the glomeruli or cortical vessels. A similar staining pattern was found in the distal and proximal tubules in rejected kidney tissue samples. However, in the rejected kidneys, the number of tubules was markedly reduced. In addition, within the glomeruli of rejected kidney samples, there was positive immunostaining for uPA, uPAR, and PAI-1 in the mesangial cells, but negative staining in most of the endothelial cells, whereas the normal kidneys revealed no immunoreactivity in these structures. The demonstrated up-regulation of uPA/uPAR/PAI-1 in chronic renal rejection is consistent with the plasminogen/plasmin system contributing to tissue remodeling in this disorder. These factors might activate latent transforming growth factor-betas, which have been reported to be enhanced in this disorder, contributing to the generation of the extracellular matrix.Keywords
This publication has 19 references indexed in Scilit:
- Expression of TGF-β1 and matrix proteins is elevated in rats with chronic rejectionKidney International, 1996
- Altered expression of transforming growth factor-βs in chronic renal rejectionKidney International, 1996
- Requirement for receptor‐bound urokinase in plasmin‐dependent cellular conversion of latent TGF‐β to TGF‐βJournal of Cellular Physiology, 1994
- Enhanced expression of transforming growth factor β isoforms in pancreatic cancer correlates with decreased survivalGastroenterology, 1993
- Glomerular matrix accumulation is linked to inhibition of the plasmin protease systemKidney International, 1992
- Overexpression of the epidermal growth factor receptor in human pancreatic cancer is associated with concomitant increases in the levels of epidermal growth factor and transforming growth factor alpha.JCI Insight, 1992
- Causes of Renal Allograft LossAnnals of Surgery, 1991
- Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extractionAnalytical Biochemistry, 1987
- The plasminogen system and cell surfaces: evidence for plasminogen and urokinase receptors on the same cell type.The Journal of cell biology, 1986
- Production of transforming growth factor beta by human T lymphocytes and its potential role in the regulation of T cell growth.The Journal of Experimental Medicine, 1986